An interventional study of Extensive bedside training for accessing patient portal and Limited bedside training on patient portal use. in Mobile Health, sponsored by University of California, San Francisco. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-06.
Sponsored by University of California, San Francisco · Not applicable, Interventional, and Supportive care
RESEARCH QUESTION:
Are hospitalized patients able to use a tablet computer (iPad) to take brief surveys, access their patient portal (MyChart), and watch informational videos about their condition?
STUDY DESIGN:
Small pilot study evaluating pre/post impressions of information technology and the feasibility of using a tablet computer for education purposes and to complete a daily survey about preparations for discharge and post-acute care.
The study has two distinct parts. Patients will have the option to participate in either one or both parts.
PART 1: Using iPads to learn about health conditions We will enroll and randomize patients to intervention or control groups. Allocation to be intervention or control group will be determined using a computer-based random number generator. All patients will be orientated to using an iPad, asked to take a pre-use survey, will have a MyChart account set up and view EMMI modules. Intervention group patients will receive specific detailed education about how to access, navigate and use MyChart using tablets (iPads) . Control group patients will not receive this specific education about how to access, navigate and use MyChart using tablets (iPads). Both intervention and control group patients will be asked to complete a post-use survey. We will access MyChart data repositories to determine if patients continue to access their patient portal for up to 30 days after the completion of this part of the study.
PART 2: Using iPads to prepare for discharge We will enrol all eligible patients (regardless of intervention or control group status in Part 1) to complete a daily Readiness for Discharge Survey (RDS). This standardized validated survey will determine a range of discharge and post-acute issues and will be fed back to the patient's health care team. Patient demographic and clinical information will be abstracted from their medical record to determine if there are any specific issues related to specific groups of patients. Initially the RDS will be completed on a paper survey but will be eventually be administered via an iPad.
University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.
Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult patients admitted to any service at UCSF Medical Center
Exclusion Criteria:
Patients not speaking English. Patients unable to give consent. Patients unable to safely use a tablet computer for any reason. Patients being discharged on day of approach. Patient cognitively impaired and unable to give consent. Patient in ICU. Patient in some form of droplet isolation.
Control patients receive iPad tablets during their hospital stay with only LIMITED bedside training from a research assistant on how to access and effectively use their patient portal.
Other: Limited bedside training on patient portal use.
Intervention patient receive iPad tablets during their hospital stay with EXTENSIVE bedside training from a research assistant on how to access and effectively use their patient portal.
Other: Extensive bedside training for accessing patient portal
EXTENSIVE bedside training from a research assistant on how to access and effectively use their patient portal.
Also known as: Apple iPad tablets, Epic MyChart patient portal
EXTENSIVE bedside training from a research assistant on how to access and effectively use their patient portal.
Patient Portal Usage
Effects of iPad intervention to improve patient access to their patient portal will be assessed during hospitalization and for 30 days after discharge.
Time frame: During and after hospitalization (up to 30 days)
This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Francisco